Dr. Eisner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
826 Main St
Ste 100
Phoenixville, PA 19460Phone+1 610-933-8484Fax+1 610-917-0320
Education & Training
Temple University HospitalFellowship, Allergy and Immunology, 1966 - 1967- Temple University HospitalResidency, Internal Medicine, 1964 - 1966
- Temple University HospitalInternship, Internal Medicine, 1963 - 1964
Albert Einstein College of MedicineClass of 1963
Certifications & Licensure
PA State Medical License 1964 - 2024- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2014
Publications & Presentations
PubMed
- 153 citationsInsights into the Development of Polycystic Ovary Syndrome (PCOS) from Studies of Prenatally Androgenized Female Rhesus MonkeysDavid H. Abbott, Daniel A. Dumesic, Joel R. Eisner, Ricki J. Colman, Joseph W. Kemnitz
Trends in Endocrinology and Metabolism. 1998-02-01 - 118 citationsPrenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthoodDaniel A. Dumesic, David H. Abbott, Joel R. Eisner, Robert W. Goy
Fertility and Sterility. 1997-01-01 - 102 citationsOvarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excessJoel R. Eisner, Melissa A. Barnett, Daniel A. Dumesic, David H. Abbott
Fertility and Sterility. 2002-01-01
Press Mentions
Advanced Bladder Cancers Respond to Immunotherapy Regardless of Gene Mutation StatusJuly 22nd, 2021
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
